341 related articles for article (PubMed ID: 22303361)
1. MicroRNAs in Hepatobiliary and Pancreatic Cancers.
Saito Y; Suzuki H; Matsuura M; Sato A; Kasai Y; Yamada K; Saito H; Hibi T
Front Genet; 2011; 2():66. PubMed ID: 22303361
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNAs in gastrointestinal cancers.
Saito Y; Suzuki H; Hibi T
J Gastroenterol; 2009; 44 Suppl 19():18-22. PubMed ID: 19148788
[TBL] [Abstract][Full Text] [Related]
3. microRNAs as oncogenes and tumor suppressors.
Zhang B; Pan X; Cobb GP; Anderson TA
Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in cancers and neurodegenerative disorders.
Saito Y; Saito H
Front Genet; 2012; 3():194. PubMed ID: 23056009
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L
Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
9. The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma.
Khan S; Zhang DY; Zhang JY; Hayat MK; Ren J; Nasir S; Fawad M; Bai Q
Front Oncol; 2022; 12():950374. PubMed ID: 35924150
[TBL] [Abstract][Full Text] [Related]
10. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
Gunaratne PH
Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets.
Xu J; An P; Winkler CA; Yu Y
Front Oncol; 2020; 10():1271. PubMed ID: 32850386
[TBL] [Abstract][Full Text] [Related]
12. MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.
Wang C; Ren R; Hu H; Tan C; Han M; Wang X; Zheng Y
Chin J Cancer Res; 2014 Feb; 26(1):17-29. PubMed ID: 24653623
[TBL] [Abstract][Full Text] [Related]
13. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
[TBL] [Abstract][Full Text] [Related]
14. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
Chen E; Xu X; Liu R; Liu T
Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma.
Nohata N; Hanazawa T; Kinoshita T; Okamoto Y; Seki N
Auris Nasus Larynx; 2013 Apr; 40(2):143-9. PubMed ID: 22831895
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of miR-506 in cancer.
Li J; Ju J; Ni B; Wang H
Oncotarget; 2016 Sep; 7(38):62778-62788. PubMed ID: 27542202
[TBL] [Abstract][Full Text] [Related]
17. Role of MicroRNAs in Hepatocellular Carcinoma.
Zhu Z; Zhang X; Wang G; Zheng H
Hepat Mon; 2014 Aug; 14(8):e18672. PubMed ID: 25337143
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.
Ge Y; Yan X; Jin Y; Yang X; Yu X; Zhou L; Han S; Yuan Q; Yang M
PLoS Genet; 2015 Dec; 11(12):e1005726. PubMed ID: 26710269
[TBL] [Abstract][Full Text] [Related]
19. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.
Luo Z; Zhang L; Li Z; Li X; Li G; Yu H; Jiang C; Dai Y; Guo X; Xiang J; Li G
BMC Med Genomics; 2012 Jan; 5():3. PubMed ID: 22260379
[TBL] [Abstract][Full Text] [Related]
20. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.
Tréhoux S; Lahdaoui F; Delpu Y; Renaud F; Leteurtre E; Torrisani J; Jonckheere N; Van Seuningen I
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2392-403. PubMed ID: 26036346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
